hyperlipoproteinemia type III
Information
- Disease name
- hyperlipoproteinemia type III
- Disease ID
- DOID:3145
- Description
- "A familial hyperlipidemia that has_material_basis_in by homozygous, compound heterozygous, or heterozygous mutation in the APOE gene on chromosome 19q13." [url:https\://omim.org/entry/617347]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00214604 | Completed | Phase 3 | Type III Dysbetalipoproteinemia | February 2005 | February 2007 |
NCT00145431 | Terminated | Phase 3 | Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. | March 2005 | December 2006 |
NCT03811223 | Unknown status | Phase 4 | Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia | August 2019 | March 2021 |
- Disase is a (Disease Ontology)
- DOID:1168
- Cross Reference ID (Disease Ontology)
- MESH:D006952
- Cross Reference ID (Disease Ontology)
- MIM:617347
- Cross Reference ID (Disease Ontology)
- NCI:C34710
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:42569002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0020479
- Exact Synonym (Disease Ontology)
- carbohydrate induced hyperlipemia
- Exact Synonym (Disease Ontology)
- familial hypercholesterolaemia with hyperlipaemia
- Exact Synonym (Disease Ontology)
- familial type 3 hyperlipoproteinemia
- Exact Synonym (Disease Ontology)
- Remnant hyperlipidemia
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006952